We tested this approach with metabolic disease genes expressed in adipocytes, identifying and subsequently validating novel interactions between BSCL2 and PLIN1 (protein–protein) as well as CEBPA and AGPAT2 (genetic regulatory). This evidence concerns the gene CEBPA and metabolic disease.